Department of Dermatology, Catharina Hospital Eindhoven, the Netherlands.
Clin Exp Dermatol. 2013 Oct;38(7):724-9. doi: 10.1111/ced.12080.
It is known that the incidence of skin cancer is rising rapidly worldwide, but no reliable figures on multiple nonmelanoma skin cancer (NMSC) are available.
To determine the actual incidence of skin cancer in dermatology practice and to estimate how this relates to the first primary tumours (registered at the Eindhoven Cancer Registry).
We examined 1001 randomly selected patient records at Catharina Hospital Eindhoven for mention of skin cancer. For each patient, skin cancers were recorded in a database, starting from 1 January 2004 until 1 March 2010. The time interval between tumours and any history of skin cancer were also recorded.
Of this group, 876 patients were treated for skin cancer during the study period. We recorded a total of 2106 tumours with a mean of 2.4 skin cancers per patient. Nearly half (46%) of patients developed multiple tumours, and the second tumour developed within a median period of 5 months. Over a quarter (28%) of patients were known to have had skin cancer before 2004, the start of the study period.
The number of NMSCs in practice differs substantially from the number of first primary histologically confirmed NMSCs, as usually reported by the Eindhoven Cancer Registry. To obtain the optimum benefit from registration of NMSC, it is recommended to register all NMSCs, because only this complete number will give an insight into the incidence of the rising skin-cancer numbers. Because subsequent tumours occur frequently, NMSC should be regarded as a chronic disease, and innovations in disease management are required for cost-effective control.
据了解,皮肤癌的发病率在全球范围内迅速上升,但尚无关于多种非黑素瘤皮肤癌(NMSC)的确切发病率数据。
确定皮肤科实践中皮肤癌的实际发病率,并估计其与第一原发性肿瘤(在埃因霍温癌症登记处登记)的关系。
我们在埃因霍温 Catharina 医院检查了 1001 份随机选择的患者记录,以了解皮肤癌的情况。对于每位患者,我们从 2004 年 1 月 1 日至 2010 年 3 月 1 日开始在数据库中记录皮肤癌。还记录了肿瘤之间的时间间隔和任何皮肤癌病史。
在该组中,876 名患者在研究期间接受了皮肤癌治疗。我们共记录了 2106 个肿瘤,平均每个患者有 2.4 个皮肤癌。近一半(46%)的患者出现了多个肿瘤,第二个肿瘤在中位时间 5 个月内发展。超过四分之一(28%)的患者在研究开始前(即 2004 年)就已经患有皮肤癌。
实践中 NMSC 的数量与通常由埃因霍温癌症登记处报告的第一原发性组织学证实的 NMSC 数量有很大差异。为了从 NMSC 的登记中获得最佳效益,建议登记所有 NMSC,因为只有这样完整的数量才能深入了解不断上升的皮肤癌数量的发病率。由于随后的肿瘤经常发生,因此应将 NMSC 视为一种慢性病,需要在疾病管理方面进行创新,以实现具有成本效益的控制。